CVRx
IPO
Our life goal is to make yours better.
- Headquarters
- Minneapolis
- Employees
- 51–200
- Founded
- 2001
- Business Model
- B2B
- Website
- cvrx.com
- Total Funding
- $205.6M
- Last Round
- $50.0M Venture RoundJul 2020
About
CVRx (Nasdaq: CVRX) is a commercial-stage medical device company founded in 2001 and headquartered in Minneapolis, Minnesota. The company develops, manufactures, and commercializes innovative neuromodulation solutions that harness the body's natural systems to improve outcomes for patients with chronic cardiovascular disease. CVRx developed Barostim, the world's first FDA-approved neuromodulation device for heart failure management.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account